InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NextCure, Inc.

NXTC Clue Score63
United States Fiscal year ends December CIK 0001661059
$7.18 +5.90% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.18 −6.02% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 9 May 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Operating income−23.2Net income−22.8Fiscal year 2019Revenue6.3Operating income−37.5Net income−33.7Fiscal year 2020Revenue22.4 +252.6%Operating income−41.2Net income−36.6EPS, diluted−1.33Fiscal year 2021Operating income−70.8Net income−69.4EPS, diluted−2.51Fiscal year 2022Operating income−75.9Net income−74.7EPS, diluted−2.69Fiscal year 2023Operating income−67.6Net income−62.7EPS, diluted−2.25Fiscal year 2024Operating income−59.7Net income−55.7EPS, diluted−23.88Fiscal year 2025Operating income−57.6Net income−55.8EPS, diluted−19.65
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 6.3 22.4 n/a n/a n/a n/a n/a
Growth +252.6%
Operating income −23.2 −37.5 −41.2 −70.8 −75.9 −67.6 −59.7 −57.6
Net income −22.8 −33.7 −36.6 −69.4 −74.7 −62.7 −55.7 −55.8
Growth
EPS, diluted n/a n/a −1.33 −2.51 −2.69 −2.25 −23.88 −19.65

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Fiscal year 2019Operating margin−590.5%Net margin−531.5%Free cash flow margin−614.4%Fiscal year 2020Operating margin−184.2%Net margin−163.6%Free cash flow margin−232.8%Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −590.5% −184.2% n/a n/a n/a n/a n/a
Net margin n/a −531.5% −163.6% n/a n/a n/a n/a n/a
Free cash flow margin n/a −614.4% −232.8% n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow8.0Capital expenditure−3.1Free cash flow4.9Fiscal year 2019Operating cash flow−35.6Capital expenditure−3.4Free cash flow−39.0 −891.1%Fiscal year 2020Operating cash flow−45.0Capital expenditure−7.1Free cash flow−52.1Fiscal year 2021Operating cash flow−57.3Capital expenditure−2.4Free cash flow−59.6Fiscal year 2022Operating cash flow−53.9Capital expenditure−2.1Free cash flow−56.0Fiscal year 2023Operating cash flow−53.0Capital expenditure−0.8Free cash flow−53.8Fiscal year 2024Operating cash flow−40.8Capital expenditure−0.5Free cash flow−41.3Fiscal year 2025Operating cash flow−49.6
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 8.0 −35.6 −45.0 −57.3 −53.9 −53.0 −40.8 −49.6
Capital expenditure −3.1 −3.4 −7.1 −2.4 −2.1 −0.8 −0.5 n/a
Free cash flow 4.9 −39.0 −52.1 −59.6 −56.0 −53.8 −41.3 n/a
Growth −891.1%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash135.2Total debt0.5Net cash (debt)134.7Shareholders’ equity−46.9Fiscal year 2019Cash34.1Total debt5.0Net cash (debt)29.1Shareholders’ equity321.5Debt to equity0.02Fiscal year 2020Cash32.8Total debt3.5Net cash (debt)29.3Shareholders’ equity293.7Debt to equity0.01Fiscal year 2021Cash12.3Total debt0.0Net cash (debt)12.3Shareholders’ equity233.4Debt to equity0.00Fiscal year 2022Cash26.6Total debt0.0Net cash (debt)26.6Shareholders’ equity167.5Debt to equity0.00Fiscal year 2023Cash13.1Shareholders’ equity114.4Fiscal year 2024Cash27.7Shareholders’ equity65.5Fiscal year 2025Cash26.0Shareholders’ equity34.9
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 135.2 34.1 32.8 12.3 26.6 13.1 27.7 26.0
Total debt 0.5 5.0 3.5 0.0 0.0 n/a n/a n/a
Net cash (debt) 134.7 29.1 29.3 12.3 26.6 n/a n/a n/a
Shareholders’ equity −46.9 321.5 293.7 233.4 167.5 114.4 65.5 34.9
Debt to equity n/a 0.02 0.01 0.00 0.00 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 6.3 22.4 n/a n/a n/a n/a n/a
Growth +252.6%
19.8 34.2 46.6 50.2 54.2 47.9 41.5 44.9
3.4 9.6 17.0 20.6 21.7 19.7 15.7 12.7
−23.2 −37.5 −41.2 −70.8 −75.9 −67.6 −59.7 −57.6
Growth
n/a n/a n/a n/a n/a n/a n/a 0.0
−22.8 −33.7 −36.6 −69.4 −74.7 −62.7 −55.7 −55.8
Growth
Per share
n/a n/a −1.33 −2.51 −2.69 −2.25 −23.88 −19.65
n/a n/a −1.33 −2.51 −2.69 −2.25 −23.88 −19.65
Growth
n/a n/a 27.5 27.6 27.7 27.8 2.3 2.8
n/a n/a 27.5 27.6 27.7 27.8 2.3 2.8
Growth +0.3% +0.5% +0.3% −91.6% +22.0%

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 8 of 8 years on file.